Skip to main content
Past Event

Engaging patients: Building trust and support for safety surveillance

The Sentinel System is a state of the art active surveillance system relying on a distributed data network to rapidly scale analysis of health care data collected from over 178 million patients nationwide. Sentinel is an important safety surveillance tool used by the U.S. Food and Drug Administration (FDA), and its underlying distributed data infrastructure is increasingly being recognized to have the potential to support the needs of diverse stakeholders including other public health agencies, health systems, regulated industry, and the clinical research enterprise. Despite Sentinel’s importance in safety surveillance, patients are largely unaware of Sentinel’s public health mission and commitment to protecting patient privacy. Therefore, it is both timely and critical to identify opportunities to raise awareness and build trust for Sentinel safety surveillance among patients, consumers, and the general public.

On June 23, the Center for Health Policy at Brookings, in collaboration with the FDA, hosted an expert workshop to discuss opportunities to raise awareness of the Sentinel System through improved communication to patients and consumers. Participants, including Sentinel Data Partners, patient focused organizations (e.g., consumer advocacy groups), experts in patient privacy, ethics, and health literacy, and representatives from the FDA explored possible opportunities where each stakeholder might be uniquely positioned to engage with patients, and how these communications could be designed and delivered effectively. Discussions from this workshop resulted in recommendations including a set of guiding principles, potential tools, and strategies to improve awareness of the Sentinel System, but more broadly, safety surveillance activities led by the FDA.


Welcome and overview


Robert Ball

Deputy Director of the Office of Surveillance and Epidemiology - U.S. Food and Drug Administration

Session I: Exploring the current patient and Sentinel data partner relationship


Jamie Brocki

Staff Vice President, Member Engagement & Communications - Anthem Inc.


Nancy Falk

Senior Director, Marketing Program Innovation, Kaiser Foundation Health Plan Inc. - Kaiser Permanente


Lyn Ketelsen

Vice President and Chief Patient Experience Officer - Hospital Corporation of America


Bray Patrick-Lake

Director of Patient Engagement - Duke Clinical and Translational Science Award


Jaewon Ryu

Segment Vice President and President, Integrated Care Delivery, MSO JV Oversight - Humana


Darla Tufto

Vice President, Consumer Office - UnitedHealthcare

Session II: Approaches to engage patients in understanding Sentinel’s public health benefits


Barbara J. Evans

Professor of Law and George Butler Research Professor; Director, Center on Biotechnology & Law - University of Houston Law Center


J. Stephen Mikita

Patient Engagement Representative for Sentinel; Planning Board Member, Mini-Sentinel - Patient Representative, Duke Clinical Trials Transformation Initiative


Sally Okun

Vice President for Advocacy, Policy and Patient Safety - PatientsLikeMe

Session III: Learning from promising mechanisms to improve patient communication and engagement


Eric Gascho

Assistant Vice President of Government Affairs - National Health Council


Jan Oldenburg

Senior Manager and Healthcare and Consumer Advisory Service - Ernst and Young


Consuelo Wilkins

Associate Professor of Medicine - Vanderbilt University School of Medicine and Meharry Medical College

Session IV: Catch all

Closing remarks

More Information


To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.

Get a weekly events calendar from Brookings